Sumamban, Nestor P.

HRN: 21-64-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2022
CEFTAZIDIME 1GM (VIAL)
07/22/2022
07/29/2022
IVTT
2g
Q8
Pulmonary Infiltrates
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: